Introduction
Paclitaxel (Taxol), a diterpene compound, was originally isolated from the stem bark of Taxus brevifolia and shown to have antiproliferative activity in various cultured cancer cells and antineoplastic activity in cancer patients (Wani et al., 1971) . These eects appear to be related to Taxol's ability to bind tubulin, to promote microtubule assembly, and to stabilize microtubules by bundle formation (Kumar, 1981; Schi et al., 1979; Schi and Horwitz, 1980) . Taxol has also been shown to alter gene expression Bogdan and Ding., 1992) . Thus, identi®cation and characterization of changes in gene expression pro®les in response to Taxol treatment may lead to a better understanding of mechanisms for Taxol-mediated activity and facilitate design of novel cancer therapies. The recently described cDNA array or DNA chip technology allows monitoring of expression of thousands of genes simultaneously and provides a format for identifying genes and changes in their activities (Shena et al., 1995; Shalon et al., 1996; Heller et al., 1997; DeRisi et al., 1996) . The p55Cdc gene product is a cell cycle protein expressed in proliferating cells but not in dierentiated, growth-arrested cells (Weinstein et al., 1994) . This protein has homology to Saccharomyces cerevisiae proteins Cdc4 and Cdc20, which are believed to regulate DNA synthesis and mitosis, respectively (Weinstein et al., 1994; Choi et al., 1990) . Furthermore, overexpression of p55Cdc in a myeloid leukemic cell line resulted in increased serum-and factor-starved apoptosis, and inducible expression increased cell death in the same cell line (Kao et al., 1996; Lin et al., 1998) . Using the cDNA array technique in this study, we found that Taxol could induce p55Cdc gene expression in HeLa cells. Taxol also induced both p55Cdc mRNA and protein expression in a dose-dependent manner. Furthermore, p55Cdc expression resulted in increased cell death, but dominant-negative p34 cdc2 could inhibit p55Cdc-induced and Taxol-induced cell death. These results suggest that p55Cdc may play a role in Taxolmediated apoptosis.
Results and discussion
To elucidate Taxol-mediated gene expression pro®les in cultured cells, we performed dierential hybridization analysis of cDNAs from HeLa, MDA-MB-435, 435-eB.1 (Her2/neu stable transfectant of MDA-MB-435) and MCF-10A cell lines grown with or without Taxol treatment and then hybridized to an Atlas cDNA expression array (Clontech). The expression of eight genes in HeLa, 18 genes in MDA-MB-435, 31 genes in 435-eB,1 and 17 genes in MCF-10A cells were upregulated with Taxol treatment (data not shown). Expression of nuclear factor 90 (NF90), fos-related antigen-2 (FRA-2), p55Cdc and transcriptional factor PAX3 were commonly high and transcriptional initiation factor TFIID subunit TAFII31, transferrin receptor, RNA polymerase II elongation factor SIII and CD44 were lower in these cell lines (data not shown). Among these, p55Cdc expression with Taxol treatment was 20-fold higher than that of nontreatment in HeLa cell (Figure 1a) , and six-or twofold higher in 435-eB.1 or MCF-10A cells (data not shown). Thus, in all three cell lines tested, the p55Cdc RNA expression was found to be increased by Taxol treatment, though the increased level is not exactly the same. To con®rm upregulation of p55Cdc expression by Taxol, we performed RT ± PCR in various cell lines. The upregulation was detected in HeLa and MCF-7 cells (Figure 1b) . To determine whether an increase in p55Cdc RNA resulted in an increase in p55Cdc protein, protein lysates were prepared from HeLa and MCF-7 cells after Taxol treatment. As shown in Figure  1c , 0.1 mM Taxol clearly caused an increase in p55Cdc protein levels in these cell lines. The p55Cdc protein is known to play a role in mitosis (Shteinberg et al., 1999; Kotani et al., 1999) , Taxol induce mitotic block at the metaphase/anaphase transition in HeLa cells by stabilizing spindle microtubles (Jordan et al., 1993) . Activity of the p55Cdc-associated myelin basic protein kinase peaks in the G2/M phase in HeLa cells, paralleling Taxol-induced mitotic block (Farruggio et al., 1999) . To examine whether Taxol could activate the p55Cdc-associated kinase, p55Cdc proteins were immunoprecipitated with anti-p55Cdc antibody from Taxol-treated or -untreated HeLa cell lysates and tested for the kinase activity of phosphorylation of myelin basic proteins. As shown in Figure 1d , Taxol not only induced expression of p55Cdc, but also enhanced activity of the p55Cdc-associated kinase.
To determine whether Taxol can induce transcriptional activity of the p55Cdc promoter, we subcloned 1000 bp of the rat p55Cdc promoter into the pGL2 vector, which contains the luciferase reporter gene. The construct was transiently transfected into HeLa cells with or without Taxol treatment, and then the transcriptional activity of the p55Cdc promoter was measured at various time. After 48 h, the relative activity of the p55Cdc-driven luciferase reporter gene was 5.6 times greater in the treated cells (Figure 2) . Thus, Taxol can activate the p55Cdc promoter and enhance p55Cdc transcription, which contributes to increased p55Cdc RNA and protein expression and p55Cdc-associated kinase activity.
When the orderly progression of the cell cycle disrupted, an abnormal mitosis (mitotic catastrophe) occurs. This aberrant process takes place when cell cycle components are overexpressed or sustain mutations (Russel and Nurse, 1987; Heald et al., 1993) . Deregulation of these cell cycle components leads to hyperactiva- (7) for 24 h and incubated with anti-p55Cdc antibody. Immunoprecipitates were assayed for associated kinase activity toward myelin basic protein (MBP). Samples were analysed by SDS ± PAGE followed by phosphoimaging Role of p55Cdc in Taxol-mediated apoptosis K Makino et al tion of cdc2 at an inappropriate time during the cell cycle. Cdk activation induced by inappropriately bypassing mitotic checkpoints may result in death to the cell in a manner similar to that seen in mitotic catastrophe (Shi et al., 1994; Meikrantz et al., 1994) . To address whether p55Cdc plays a functional role in Taxol-mediated responses, we examined the eect of increased p55Cdc expression on programmed cell death. We ampli®ed the full-length ORF of the p55Cdc cDNA, which was subcloned into pCGN-p55Cdc and transiently transfected into HeLa cells and 293T cells ( Figure  3a ). Overexpression of HA-tagged p55Cdc resulted in decreased expression of cyclin B1 ( Figure 3a ). These ®nding indicate that overexpression of p55Cdc results in activation of cyclosome/anaphase promoting complex (APC). Next, we asked whether overexpression of p55Cdc results in decrease in cell viability. The pCGNp55Cdc expression vector were cotransfected with a pCMV-luciferase reporter gene construct which expressed in living cells but not in dead cells. Luciferase activity was quantitated and normalized by b-gal activity. Expression of p55Cdc resulted in decreased survival in a dose-dependent manner (Figure 3b ). Thus, upregulation of p55Cdc expression can activate cyclosome/APC and lead to decrease cell viability. Since Taxol can induce both cell death and p55Cdc expression, we ask whether Taxol-induced p55Cdc expression may contribute to Taxol-induced apoptosis. We had previously shown that activation of p34 cdc2 at G2/M phase of cell cycle is required for Taxol-induced apoptosis in breast cancer cells because Taxol-mediated activation of p34 cdc2 kinase occurred prior to Taxolinduced apoptosis and inhibition of Taxol-mediated activation of p34 cdc2 kinase by the dominant-negative mutant of p34 cdc2 diminished Taxol-induced apoptosis (Yu et al., 1998) . Because p55Cdc is phosphorylated by cdc2-cyclinB, and this phosphorylation is required for p55Cdc-dependent cyclosome/APC activation (Kotani et al., 1999) , we therefore investigate whether Taxolinduced p34 cdc2 activation is involved in Taxol-mediated  p55Cdc activation and if a potential relationship  between p34 cdc2 and p55Cdc induces cell death. We Twenty-four hours after transfection, medium were changed to serum free conditions and cells were incubated for another 48 h. Cells were harvested, luciferase activity was measured, and survival ratios (HA-p55Cdc/vector only) were determined. Data represent the average of three independent experiments. HA-tagged p55Cdc protein expression was con®rmed by Western blot analysis using anti-HA antibody cotransfected pCGN-p55Cdc and pCMV-cdc2-dn expression vectors into HeLa cells. The dominantnegative mutant of cdc2 inhibited p55Cdc-induced (Figure 4a-1) and Taxol-induced cell death ( Figure  4a -2), but not serum-starved cell death (Figure 4a-3) . Thus, the pathways of p55Cdc-and Taxol-induced cell death seems to be dierent from serum-starved induced cell death. The overexpression of p55Cdc resulted in decrease in expression of cyclin B1. However, coexpression of dominant-negative cdc2 inhibited p55Cdc overexpression mediated cyclin B1 regulation ( Figure  4b ). Furthermore, forced expression of p55Cdc and Taxol treatment resulted in activation of the p55Cdc-associated kinase. Expression of dominant-negative cdc2 inhibited p55Cdc overexpression-and Taxolinduced p55Cdc-associated kinase activity (Figure 4c ).
The expression level of p55Cdc is known to¯uctuate during the cell cycle. Protein levels of p55Cdc peak in M phase and phosphorylation of p55Cdc is detected during mitosis (Weinstein, 1997; Kramer et al., 1998) . To study whether the Taxol-induced expression of p55Cdc occurred as a result of mitotic-arrest by Taxol, cells were synchronized at the G1/S boundary by double thymidine block and then treated with Taxol for 8 h. Both mRNA and protein levels of p55Cdc were low at G1/S boundary (Figure 5a,b) . However, increased expression of both mRNA and protein of p55Cdc were observed after 8 h Taxol treatments (Figure 5a,b) . Furthermore, when cells were treated at 8 h after the release from thymidine block, there is no increase in p55Cdc expression. As a matter of fact, double block was observed and protein level was (1) 2.5 mg of HA-tagged p55Cdc expression vectors or control empty vectors were cotransfected into HeLa cells with DN-cdc2 or empty vectors (Mock) and with luciferase and b-gal plasmids normalizing transfection eciencies. Luciferase activity was measured, and survival ratios (HAp55Cdc/vector only) were determined. Per cent cell death were calculated by subtraction the numbers of survival ratios of HAp55Cdc from these of empty vector and compared between DN-cdc2 and Mock transfections. (2,3) HeLa cells were cotransfected with DN-cdc2 or empty vectors (Mock) and luciferase and b-gal plasmids. Luciferase activity was measured, survival ratios (Taxol/ nontreatment or serum-starved/nontreatment) were determined. Per cent cell death were calculated by subtraction the numbers of survival ratios of Taxol treatment or serum-starvation treatment from these of nontreatment and compared between DN-cdc2 and Mock transfections. Data represent the average of three independent experiments. (b) Inhibition of p55Cdc-mediated APC/ cyclosome activation by DN-cdc2. HA-tagged p55Cdc expression vectors or control empty vectors were cotransfected into 293T cells with DN-cdc2 or empty vectors (Mock). The transfection eciency of 293 T is approximately 30 ± 40% under our standard protocols. The cell lysates were immunoblotted with anti-p55Cdc, anti-Cyclin B1 and anti-cdc2 antibodies. Actin was used as a protein loading control. (c) Inhibition of p55Cdc-induced and Taxol-induced p55Cdc associated kinase activity by DN-cdc2. Cells were treated as in a and were collected and assayed for p55Cdc-associated kinase activity as in Figure 1D . The protein levels of HA and p55Cdc were determined by Western blot analysis. Actin was used as a protein loading control reduced (Figure 5b) . Thus, these ®ndings suggest that increased p55Cdc expression is probably induced as a result of mitotic-arrest by Taxol.
As mentioned previously, p55Cdc-associated kinase activity is correlated with Taxol-induced mitotic block. This mitotic block is followed by an abnormal exit from mitosis into an interphase-like state with no accompanying cytokinesis. The block appears to be sucient to inhibit further cell proliferation and to induce cell death by apoptosis (Jordan et al., 1996) . In the present work, we showed that Taxol can induce p55Cdc, which is a known regulator of mitosis. The data suggest that Taxol induces cell death not only by regulating stabilization of microtubles but also by directly regulating mitotic regulators. In this regard, both transcriptional upregulation of p55Cdc and activation of p55Cdc by Taxol-mediated p34 cdc2 kinase activity may contribute to the Taxol-induced cell death (Figure 5c ).
Materials and methods

Cell culture
HeLa cells (human epithelioid cervical cancer cell line), NIH3T3 cells (mouse ®broblast cell lines) and human breast cancer cell lines MCF-7 and MDA-MB-435 were maintained in DMEM/F12 medium containing 10% fetal bovine serum (378C, 5% CO 2 ). The 435-eB transfectants were established and cultured as previously reported (Yu et al., 1996) . MCF-10A cells (normal human breast epithelial cell line) were maintained in DMEM/F12 medium containing 5% horse serum with insulin (10 mg/ml), epidermal growth factor (20 ng/ml), cholera endotoxin (100 ng/ml), hydrocortisone (0.5 mg/ml), and calcium (1.05 mM). Cells were seeded at densities of 1610 5 cells/ml so that they grew in log phase for the duration of each experiment. Two days after seeding, cells were grown in fresh medium with Taxol (0.1 mM) or without Taxol (Bristol-Meyers Squibb Co.) for 24 h.
Differential hybridization of cDNA expression arrays
Total RNA was isolated from cells using Trizol reagent (Life Technologies) according to the protocol recommended by the manufacturer. Poly (A) + RNA was puri®ed from 250 ± 300 mg of total RNA using the Oligotex puri®cation (QIAGEN) according to the protocol recommended by the manufacturer. RNA was precipitated at 7708C for 1 h with 3 M sodium acetate (pH 5.2) and 100% ethanol. After drying, the RNA pellet was resuspended in 7.5 ml of DEPC-treated water and 2 ml of CDS primer (0.02 mM) (Clontech) and incubated at 708C for 10 min. After placing the reaction mixture on ice, 2 ml of 106reaction buer, 2 ml of 25 mM MgCl 2 , 1 ml of dNTPs (5 mM dATP, dGTP, and dTTP and 50 nM dCTP), 2 ml of 100 mM DTT and 3.5 ml of Figure 5 Eect of mitotic arrest on both mRNA and protein expression of p55Cdc. HeLa cells were synchronized at the G1/S boundary by double thymidine block and released into the cell cycle. The cells were then exposed to Taxol (0.1 mM, (+)) for 8 h at the beginning of the release from thymidine block (most of cells were in G1/S phase) or at 8 h after the release from thymidine block (M phase) in the absence of serum. After 8 h incubation, cells were harvested and both RNA and cell lysates were prepared. (a) p55Cdc gene expression was analysed by RT ± PCR. GAPDH was used as a control. (b) The cell lysates were immunoblotted with anti-p55Cdc, anti-Cyclin B1 and cdc2 antibodies. Actin was used as a protein loading control. (c) A model to demonstrate Taxol-mediated cell death through p34 cdc2 and p55Cdc
[a-32 P]dCTP (10 mCi) were added, and the mixture was incubated at 428C for 5 min. One microliter of SuperScriptII reverse transcriptase (Life Technologies) was added, and incubated at 428C for 1 h. After puri®cation using a spin column, cDNAs were hybridized to two Atlas human cDNA expression arrays (Clontech) in separate bags for 18 h at 508C. After washing with 0.16SSC and 0.1% SDS at room temperature for 10 min and with 0.36SSC and 0.1% SDS at 688C for 30 min, the expression arrays were exposed to a phosphoimaging plate for 18 h. The data were analysed using ImageQuant software (Molecular Dynamics). The GAPDH gene was used as an internal control for hybridization eciency and cDNA concentration.
RT ± PCR
Reverse transcription was performed on 5 mg of total RNA using the SuperScript preampli®cation system (Life Technologies). The full-length ORF of the p55Cdc cDNA was ampli®ed by PCR from 5% of the RT products using forward primer (5'-GGGCTCTAGAATGGCACAGTTC-3') and reverse primer (5'-GGGTTCTAGATCAGCGGATG-CCT-3'), both containing a XbaI site (underlined). Thirty cycles of RT ± PCR were performed with denaturation 948C for 1 min, annealing at 608C for 1 min, and extension at 728C for 1 min. Products were analysed by electrophoresis through a 1% agarose gel.
Western blotting
Equal amounts of protein from cell lysates were separated on 8% polyacrylamide gels and transferred to nitrocellulose ®lters. Each ®lter was blocked at room temperature for 1 h with PBS containing 0.05% Tween 20 and 5% dry milk. They were then incubated at 48C overnight in the same solution with anti-HA antibody (1 : 1000) (BoehringerMannheim Corp.), anti-p55Cdc antibody (1 : 600) (Santa Cruz), anti-CyclinB1 antibody (1 : 1000) (Neo Marker), anticdc2 antibody (1 : 1000) (Neo Marker), or anti-actin antibody (1 : 3000) (Sigma). The ®lters were washed three times for 10 min each in PBS containing 0.05% Tween 20, and then incubated with horseradish peroxidase-conjugated anti-mouse IgG antibody against HA, anti-goat IgG antibody against p55Cdc, or anti-rabbit IgG antibody against CyclinB1, cdc2 and actin (Boehringer-Mannheim Corp.) for 40 min. Speci®c proteins were detected using an enhanced chemiluminescence system (Amersham Corp.).
Immunoprecipitation and kinase assays
293T cells were cotransfected with pCGN-p55Cdc or a pGEM control vector and either pCMVcdc2-dn (a dominant negative p34 cdc2 expression vector) or a pCDNA3 control vector encapsulated in DC-Chol liposome. Forty-eight hours later, cells were lysed with immunoprecipitation (IP) buer [0.5% NP-40, 150 mM NaCl, 50 mM Tris (pH 8.0)] containing 2% aprotinin, 5 mM PMSF, 100 mM NaF, 2 mM Na 3 VO 4 and 1 mM EDTA. Five hundred micrograms of protein from each sample was incubated at 48C with 1 mg of antibody overnight and for another 2 h after addition of protein Gagarose. The immunoprecipitates were washed three times with IP buer and twice with kinase buer [20 mM HEPES (pH 7.4), 150 mM KCl, 5 mM MnCl 2 , 5 mM NaF, 1 mM DTT] and then resuspended in 40 ml of kinase buer containing 5 mg of myelin basic protein and 10 mCi of [g7 32 P]ATP. Following 30 min incubations at 308C, the reactions were terminated with 40 ml of 26Laemmli SDS sample buer. Samples were incubated for 5 min at 968C and resolved by 15% SDS ± PAGE.
Cloning of the p55Cdc promoter and generation of a p55Cdc promoter-luciferase reporter construct Rat genomic DNA was isolated from the normal rat ®broblast cell line Rat1 using Insta gane Matrix (Bio-Rad) according to the protocol recommended by the manufacturer. A 1000 bp region of the rat p55Cdc promoter was ampli®ed by PCR using forward primer (5'-CCCAAGCTTGGGGCTTCCCTTCTTC-3') and reverse primer (5'-TAAAGCTTCGCCGAACAGTTATT-3'), both containing a HindIII site (underlined). Thirty-®ve cycles were performed with denaturation at 958C for 1 min, annealing at 558C for 1 min, and extension at 728C for 1 min. The PCR fragments were digested with HindIII, and ligated into a pGL2 vector (Promega) containing a luciferase reporter gene. DNA sequencing of double-strand plasmid DNAs was performed at DNA Core Facility in MD Anderson Cancer Center.
Luciferase assays
HeLa cells were cotransfected with the pGL2-p55Cdc promoter vector and a b-actin-lacZ vector using the cationic liposome method. Cells were lysed with 16lysis buer (Promega) after 9, 24, 36 and 48 h. After centrifugation, half of the supernatant was used for a b-galactosidase (b-gal) assay to determine transfection eciency, and one-sixth was added to reconstituted luciferase assay reagent in a luciferase assay kit (Promega). Light emission was detected by a luminometer.
Construction of the p55Cdc expression vector.
The full-length ORF of the p55Cdc cDNA was ampli®ed by PCR from RT-products from HeLa mRNA by the forward primer (5'-GGGCTCTAGAATGGCACAGTTC-3') and reverse primer (5'-GGGTTCTAGATCAGCGGATGCCT-3'), both containing a XbaI site (underlined). The PCR fragments were digested with XbaI and ligated into a pCGN expression vector containing an HA epitope tag at the NH2 terminal. DNA sequencing of double-strand plasmid DNAs was performed at DNA Core Facility in MD Anderson Cancer Center. To express HA epitope-tagged p55Cdc, the pCGNp55Cdc vector was transfected into HeLa cells by the liposome-mediated gene transfer method.
Double thymidine cell cycle synchronization at G1/S phase
HeLa cells were treated with 1 mM thymidine for 24 h, followed by a 8 h release in fresh DMEM/F12 medium with 10% fetal bovine serum and successive retreatment with thymidine for 14 h and released to enter cell cycle (Lu and Hunter, 1995) 
